The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global OTC Gastrointestinal Products Market Research Report 2025
Synopsis
OTC gastrointestinal agents include many different classes of drugs that are used to treat gastrointestinal disorders.
The global OTC Gastrointestinal Products market was valued at US$ 5900.7 million in 2023 and is anticipated to reach US$ 8483.1 million by 2030, witnessing a CAGR of 5.4% during the forecast period 2024-2030.
North American market for OTC Gastrointestinal Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for OTC Gastrointestinal Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of OTC Gastrointestinal Products include GlaxoSmithKline, Merck, Novartis, Bayer, Pfizer and Bristol-Myers Squibb, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for OTC Gastrointestinal Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Gastrointestinal Products.
Report Scope
The OTC Gastrointestinal Products market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global OTC Gastrointestinal Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Gastrointestinal Products manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Merck
Novartis
Bayer
Pfizer
Bristol-Myers Squibb
Segment by Type
H2 Receptor Antagonists
Proton Pump Inhibitors (PPIs)
Segment by Application
Hospital Pharmacies
Drug Stores
Retail Stores
E-Commerce
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of OTC Gastrointestinal Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of OTC Gastrointestinal Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
OTC gastrointestinal agents include many different classes of drugs that are used to treat gastrointestinal disorders.
The global OTC Gastrointestinal Products market was valued at US$ 5900.7 million in 2023 and is anticipated to reach US$ 8483.1 million by 2030, witnessing a CAGR of 5.4% during the forecast period 2024-2030.
North American market for OTC Gastrointestinal Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for OTC Gastrointestinal Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of OTC Gastrointestinal Products include GlaxoSmithKline, Merck, Novartis, Bayer, Pfizer and Bristol-Myers Squibb, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for OTC Gastrointestinal Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Gastrointestinal Products.
Report Scope
The OTC Gastrointestinal Products market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global OTC Gastrointestinal Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Gastrointestinal Products manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Merck
Novartis
Bayer
Pfizer
Bristol-Myers Squibb
Segment by Type
H2 Receptor Antagonists
Proton Pump Inhibitors (PPIs)
Segment by Application
Hospital Pharmacies
Drug Stores
Retail Stores
E-Commerce
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of OTC Gastrointestinal Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of OTC Gastrointestinal Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 OTC Gastrointestinal Products Market Overview
1.1 Product Overview and Scope of OTC Gastrointestinal Products
1.2 OTC Gastrointestinal Products Segment by Type
1.2.1 Global OTC Gastrointestinal Products Market Value Comparison by Type (2024-2030)
1.2.2 H2 Receptor Antagonists
1.2.3 Proton Pump Inhibitors (PPIs)
1.3 OTC Gastrointestinal Products Segment by Application
1.3.1 Global OTC Gastrointestinal Products Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Retail Stores
1.3.5 E-Commerce
1.4 Global OTC Gastrointestinal Products Market Size Estimates and Forecasts
1.4.1 Global OTC Gastrointestinal Products Revenue 2019-2030
1.4.2 Global OTC Gastrointestinal Products Sales 2019-2030
1.4.3 Global OTC Gastrointestinal Products Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 OTC Gastrointestinal Products Market Competition by Manufacturers
2.1 Global OTC Gastrointestinal Products Sales Market Share by Manufacturers (2019-2024)
2.2 Global OTC Gastrointestinal Products Revenue Market Share by Manufacturers (2019-2024)
2.3 Global OTC Gastrointestinal Products Average Price by Manufacturers (2019-2024)
2.4 Global OTC Gastrointestinal Products Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of OTC Gastrointestinal Products, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of OTC Gastrointestinal Products, Product Type & Application
2.7 OTC Gastrointestinal Products Market Competitive Situation and Trends
2.7.1 OTC Gastrointestinal Products Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest OTC Gastrointestinal Products Players Market Share by Revenue
2.7.3 Global OTC Gastrointestinal Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 OTC Gastrointestinal Products Retrospective Market Scenario by Region
3.1 Global OTC Gastrointestinal Products Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global OTC Gastrointestinal Products Global OTC Gastrointestinal Products Sales by Region: 2019-2030
3.2.1 Global OTC Gastrointestinal Products Sales by Region: 2019-2024
3.2.2 Global OTC Gastrointestinal Products Sales by Region: 2025-2030
3.3 Global OTC Gastrointestinal Products Global OTC Gastrointestinal Products Revenue by Region: 2019-2030
3.3.1 Global OTC Gastrointestinal Products Revenue by Region: 2019-2024
3.3.2 Global OTC Gastrointestinal Products Revenue by Region: 2025-2030
3.4 North America OTC Gastrointestinal Products Market Facts & Figures by Country
3.4.1 North America OTC Gastrointestinal Products Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America OTC Gastrointestinal Products Sales by Country (2019-2030)
3.4.3 North America OTC Gastrointestinal Products Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe OTC Gastrointestinal Products Market Facts & Figures by Country
3.5.1 Europe OTC Gastrointestinal Products Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe OTC Gastrointestinal Products Sales by Country (2019-2030)
3.5.3 Europe OTC Gastrointestinal Products Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific OTC Gastrointestinal Products Market Facts & Figures by Country
3.6.1 Asia Pacific OTC Gastrointestinal Products Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific OTC Gastrointestinal Products Sales by Country (2019-2030)
3.6.3 Asia Pacific OTC Gastrointestinal Products Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America OTC Gastrointestinal Products Market Facts & Figures by Country
3.7.1 Latin America OTC Gastrointestinal Products Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America OTC Gastrointestinal Products Sales by Country (2019-2030)
3.7.3 Latin America OTC Gastrointestinal Products Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa OTC Gastrointestinal Products Market Facts & Figures by Country
3.8.1 Middle East and Africa OTC Gastrointestinal Products Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa OTC Gastrointestinal Products Sales by Country (2019-2030)
3.8.3 Middle East and Africa OTC Gastrointestinal Products Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global OTC Gastrointestinal Products Sales by Type (2019-2030)
4.1.1 Global OTC Gastrointestinal Products Sales by Type (2019-2024)
4.1.2 Global OTC Gastrointestinal Products Sales by Type (2025-2030)
4.1.3 Global OTC Gastrointestinal Products Sales Market Share by Type (2019-2030)
4.2 Global OTC Gastrointestinal Products Revenue by Type (2019-2030)
4.2.1 Global OTC Gastrointestinal Products Revenue by Type (2019-2024)
4.2.2 Global OTC Gastrointestinal Products Revenue by Type (2025-2030)
4.2.3 Global OTC Gastrointestinal Products Revenue Market Share by Type (2019-2030)
4.3 Global OTC Gastrointestinal Products Price by Type (2019-2030)
5 Segment by Application
5.1 Global OTC Gastrointestinal Products Sales by Application (2019-2030)
5.1.1 Global OTC Gastrointestinal Products Sales by Application (2019-2024)
5.1.2 Global OTC Gastrointestinal Products Sales by Application (2025-2030)
5.1.3 Global OTC Gastrointestinal Products Sales Market Share by Application (2019-2030)
5.2 Global OTC Gastrointestinal Products Revenue by Application (2019-2030)
5.2.1 Global OTC Gastrointestinal Products Revenue by Application (2019-2024)
5.2.2 Global OTC Gastrointestinal Products Revenue by Application (2025-2030)
5.2.3 Global OTC Gastrointestinal Products Revenue Market Share by Application (2019-2030)
5.3 Global OTC Gastrointestinal Products Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline OTC Gastrointestinal Products Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GlaxoSmithKline OTC Gastrointestinal Products Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck OTC Gastrointestinal Products Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck OTC Gastrointestinal Products Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis OTC Gastrointestinal Products Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis OTC Gastrointestinal Products Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Corporation Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer OTC Gastrointestinal Products Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bayer OTC Gastrointestinal Products Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer OTC Gastrointestinal Products Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer OTC Gastrointestinal Products Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Corporation Information
6.6.2 Bristol-Myers Squibb Description and Business Overview
6.6.3 Bristol-Myers Squibb OTC Gastrointestinal Products Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bristol-Myers Squibb OTC Gastrointestinal Products Product Portfolio
6.6.5 Bristol-Myers Squibb Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 OTC Gastrointestinal Products Industry Chain Analysis
7.2 OTC Gastrointestinal Products Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 OTC Gastrointestinal Products Production Mode & Process
7.4 OTC Gastrointestinal Products Sales and Marketing
7.4.1 OTC Gastrointestinal Products Sales Channels
7.4.2 OTC Gastrointestinal Products Distributors
7.5 OTC Gastrointestinal Products Customers
8 OTC Gastrointestinal Products Market Dynamics
8.1 OTC Gastrointestinal Products Industry Trends
8.2 OTC Gastrointestinal Products Market Drivers
8.3 OTC Gastrointestinal Products Market Challenges
8.4 OTC Gastrointestinal Products Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global OTC Gastrointestinal Products Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global OTC Gastrointestinal Products Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global OTC Gastrointestinal Products Market Competitive Situation by Manufacturers in 2023
Table 4. Global OTC Gastrointestinal Products Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global OTC Gastrointestinal Products Sales Market Share by Manufacturers (2019-2024)
Table 6. Global OTC Gastrointestinal Products Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global OTC Gastrointestinal Products Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market OTC Gastrointestinal Products Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of OTC Gastrointestinal Products, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of OTC Gastrointestinal Products, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of OTC Gastrointestinal Products, Product Type & Application
Table 12. Global Key Manufacturers of OTC Gastrointestinal Products, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global OTC Gastrointestinal Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Gastrointestinal Products as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global OTC Gastrointestinal Products Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global OTC Gastrointestinal Products Sales by Region (2019-2024) & (K Units)
Table 18. Global OTC Gastrointestinal Products Sales Market Share by Region (2019-2024)
Table 19. Global OTC Gastrointestinal Products Sales by Region (2025-2030) & (K Units)
Table 20. Global OTC Gastrointestinal Products Sales Market Share by Region (2025-2030)
Table 21. Global OTC Gastrointestinal Products Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global OTC Gastrointestinal Products Revenue Market Share by Region (2019-2024)
Table 23. Global OTC Gastrointestinal Products Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global OTC Gastrointestinal Products Revenue Market Share by Region (2025-2030)
Table 25. North America OTC Gastrointestinal Products Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America OTC Gastrointestinal Products Sales by Country (2019-2024) & (K Units)
Table 27. North America OTC Gastrointestinal Products Sales by Country (2025-2030) & (K Units)
Table 28. North America OTC Gastrointestinal Products Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America OTC Gastrointestinal Products Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe OTC Gastrointestinal Products Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe OTC Gastrointestinal Products Sales by Country (2019-2024) & (K Units)
Table 32. Europe OTC Gastrointestinal Products Sales by Country (2025-2030) & (K Units)
Table 33. Europe OTC Gastrointestinal Products Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe OTC Gastrointestinal Products Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific OTC Gastrointestinal Products Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific OTC Gastrointestinal Products Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific OTC Gastrointestinal Products Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific OTC Gastrointestinal Products Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific OTC Gastrointestinal Products Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America OTC Gastrointestinal Products Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America OTC Gastrointestinal Products Sales by Country (2019-2024) & (K Units)
Table 42. Latin America OTC Gastrointestinal Products Sales by Country (2025-2030) & (K Units)
Table 43. Latin America OTC Gastrointestinal Products Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America OTC Gastrointestinal Products Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa OTC Gastrointestinal Products Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa OTC Gastrointestinal Products Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa OTC Gastrointestinal Products Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa OTC Gastrointestinal Products Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa OTC Gastrointestinal Products Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global OTC Gastrointestinal Products Sales (K Units) by Type (2019-2024)
Table 51. Global OTC Gastrointestinal Products Sales (K Units) by Type (2025-2030)
Table 52. Global OTC Gastrointestinal Products Sales Market Share by Type (2019-2024)
Table 53. Global OTC Gastrointestinal Products Sales Market Share by Type (2025-2030)
Table 54. Global OTC Gastrointestinal Products Revenue (US$ Million) by Type (2019-2024)
Table 55. Global OTC Gastrointestinal Products Revenue (US$ Million) by Type (2025-2030)
Table 56. Global OTC Gastrointestinal Products Revenue Market Share by Type (2019-2024)
Table 57. Global OTC Gastrointestinal Products Revenue Market Share by Type (2025-2030)
Table 58. Global OTC Gastrointestinal Products Price (USD/Unit) by Type (2019-2024)
Table 59. Global OTC Gastrointestinal Products Price (USD/Unit) by Type (2025-2030)
Table 60. Global OTC Gastrointestinal Products Sales (K Units) by Application (2019-2024)
Table 61. Global OTC Gastrointestinal Products Sales (K Units) by Application (2025-2030)
Table 62. Global OTC Gastrointestinal Products Sales Market Share by Application (2019-2024)
Table 63. Global OTC Gastrointestinal Products Sales Market Share by Application (2025-2030)
Table 64. Global OTC Gastrointestinal Products Revenue (US$ Million) by Application (2019-2024)
Table 65. Global OTC Gastrointestinal Products Revenue (US$ Million) by Application (2025-2030)
Table 66. Global OTC Gastrointestinal Products Revenue Market Share by Application (2019-2024)
Table 67. Global OTC Gastrointestinal Products Revenue Market Share by Application (2025-2030)
Table 68. Global OTC Gastrointestinal Products Price (USD/Unit) by Application (2019-2024)
Table 69. Global OTC Gastrointestinal Products Price (USD/Unit) by Application (2025-2030)
Table 70. GlaxoSmithKline Corporation Information
Table 71. GlaxoSmithKline Description and Business Overview
Table 72. GlaxoSmithKline OTC Gastrointestinal Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. GlaxoSmithKline OTC Gastrointestinal Products Product
Table 74. GlaxoSmithKline Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck OTC Gastrointestinal Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Merck OTC Gastrointestinal Products Product
Table 79. Merck Recent Developments/Updates
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis OTC Gastrointestinal Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Novartis OTC Gastrointestinal Products Product
Table 84. Novartis Recent Developments/Updates
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Business Overview
Table 87. Bayer OTC Gastrointestinal Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Bayer OTC Gastrointestinal Products Product
Table 89. Bayer Recent Developments/Updates
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer OTC Gastrointestinal Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Pfizer OTC Gastrointestinal Products Product
Table 94. Pfizer Recent Developments/Updates
Table 95. Bristol-Myers Squibb Corporation Information
Table 96. Bristol-Myers Squibb Description and Business Overview
Table 97. Bristol-Myers Squibb OTC Gastrointestinal Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Bristol-Myers Squibb OTC Gastrointestinal Products Product
Table 99. Bristol-Myers Squibb Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. OTC Gastrointestinal Products Distributors List
Table 103. OTC Gastrointestinal Products Customers List
Table 104. OTC Gastrointestinal Products Market Trends
Table 105. OTC Gastrointestinal Products Market Drivers
Table 106. OTC Gastrointestinal Products Market Challenges
Table 107. OTC Gastrointestinal Products Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of OTC Gastrointestinal Products
Figure 2. Global OTC Gastrointestinal Products Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global OTC Gastrointestinal Products Market Share by Type in 2023 & 2030
Figure 4. H2 Receptor Antagonists Product Picture
Figure 5. Proton Pump Inhibitors (PPIs) Product Picture
Figure 6. Global OTC Gastrointestinal Products Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global OTC Gastrointestinal Products Market Share by Application in 2023 & 2030
Figure 8. Hospital Pharmacies
Figure 9. Drug Stores
Figure 10. Retail Stores
Figure 11. E-Commerce
Figure 12. Global OTC Gastrointestinal Products Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global OTC Gastrointestinal Products Market Size (2019-2030) & (US$ Million)
Figure 14. Global OTC Gastrointestinal Products Sales (2019-2030) & (K Units)
Figure 15. Global OTC Gastrointestinal Products Average Price (USD/Unit) & (2019-2030)
Figure 16. OTC Gastrointestinal Products Report Years Considered
Figure 17. OTC Gastrointestinal Products Sales Share by Manufacturers in 2023
Figure 18. Global OTC Gastrointestinal Products Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest OTC Gastrointestinal Products Players: Market Share by Revenue in 2023
Figure 20. OTC Gastrointestinal Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global OTC Gastrointestinal Products Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America OTC Gastrointestinal Products Sales Market Share by Country (2019-2030)
Figure 23. North America OTC Gastrointestinal Products Revenue Market Share by Country (2019-2030)
Figure 24. U.S. OTC Gastrointestinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada OTC Gastrointestinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe OTC Gastrointestinal Products Sales Market Share by Country (2019-2030)
Figure 27. Europe OTC Gastrointestinal Products Revenue Market Share by Country (2019-2030)
Figure 28. Germany OTC Gastrointestinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France OTC Gastrointestinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. OTC Gastrointestinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy OTC Gastrointestinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia OTC Gastrointestinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific OTC Gastrointestinal Products Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific OTC Gastrointestinal Products Revenue Market Share by Region (2019-2030)
Figure 35. China OTC Gastrointestinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan OTC Gastrointestinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea OTC Gastrointestinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India OTC Gastrointestinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia OTC Gastrointestinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan OTC Gastrointestinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia OTC Gastrointestinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand OTC Gastrointestinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia OTC Gastrointestinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines OTC Gastrointestinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America OTC Gastrointestinal Products Sales Market Share by Country (2019-2030)
Figure 46. Latin America OTC Gastrointestinal Products Revenue Market Share by Country (2019-2030)
Figure 47. Mexico OTC Gastrointestinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil OTC Gastrointestinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina OTC Gastrointestinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa OTC Gastrointestinal Products Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa OTC Gastrointestinal Products Revenue Market Share by Country (2019-2030)
Figure 52. Turkey OTC Gastrointestinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia OTC Gastrointestinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.A.E OTC Gastrointestinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of OTC Gastrointestinal Products by Type (2019-2030)
Figure 56. Global Revenue Market Share of OTC Gastrointestinal Products by Type (2019-2030)
Figure 57. Global OTC Gastrointestinal Products Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of OTC Gastrointestinal Products by Application (2019-2030)
Figure 59. Global Revenue Market Share of OTC Gastrointestinal Products by Application (2019-2030)
Figure 60. Global OTC Gastrointestinal Products Price (USD/Unit) by Application (2019-2030)
Figure 61. OTC Gastrointestinal Products Value Chain
Figure 62. OTC Gastrointestinal Products Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
